JLJe-Ho Lee

Je-Ho Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Je-Ho Lee has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Dojin Kim

    Molecular Therapy Research Center, Sungkyunkwan University, Samsung Medical Center Annex 8F, Kangnam-ku, Seoul, Korea

    1 shared publication
  • Jinhee Park

    Molecular Therapy Research Center, Sungkyunkwan University, Samsung Medical Center Annex 8F, Kangnam-ku, Seoul, Korea

    1 shared publication
  • Kwangbae Kim

    Molecular Therapy Research Center, Sungkyunkwan University, Samsung Medical Center Annex 8F, Kangnam-ku, Seoul, Korea

    1 shared publication
  • Kyoungsook Park

    Molecular Therapy Research Center, Sungkyunkwan University, Samsung Medical Center Annex 8F, 50 Ilwon-dong, Kangnam-ku, Seoul 135-710, Korea

    1 shared publication
  • Kyusam Choi

    Molecular Therapy Research Center, Sungkyunkwan University, Samsung Medical Center Annex 8F, Kangnam-ku, Seoul, Korea

    1 shared publication
  • Seung Bae Rho

    Molecular Therapy Research Center, Sungkyunkwan University, Samsung Medical Center Annex 8F, Kangnam-ku, Seoul, Korea

    1 shared publication

Latest Publications

  • Open Access

    Homeobox Msx1 Interacts with p53 Tumor Suppressor and Inhibits Tumor Growth by Inducing Apoptosis

    by Kyoungsook Park, Kwangbae Kim, Seung Bae Rho, Kyusam Choi, Dojin Kim, Sun-Hee Oh, Jinhee Park, Seung-Hoon Lee, Je-Ho Lee

    The stability of wild-type p53 is critical for its apoptotic function. In some cancers, wild-type p53 is inactivated by interaction with viral and cellular proteins, and restoration of its activity has therapeutic potential. Here, we identify homeobox Msx1 as a p53-interacting protein and show its novel function as a p53 regulator. Overexpression of homeobox Msx1 induced apoptosis of cancer cells harboring nonfunctional wild-type p53 and suppressed growth of human tumor xenografts in nude mice. The homeodomain of Msx1 functions as a protein-protein interacting motif rather than a DNA-binding domain and is essential for stabilization, nuclear accumulation, and apoptotic function of wild-type p53. The identification of a novel function of Msx1 as a p53 regulator may open new avenues for developing improved molecular therapies for tumors with a nonmutational p53 inactivation mechanism.